QGEN Latest Press Releases

-- November 6, 2026 --

QIAGEN Shareholders Overwhelmingly Approve Jonathan M. Pratt as Managing Director Business Wire 10:00 AM

-- November 4, 2026 --

QIAGEN Reports Full Q3 2026 Results Business Wire 4:05 PM

-- October 28, 2026 --

Halper Sadeh LLC is Investigating Whether ULBI, QGEN, CCC, PAG are Obtaining Fair Deals for their Shareholders Globe Newswire 10:48 AM

-- October 22, 2026 --

Halper Sadeh LLC is Investigating Whether QGEN, VCTR, RLYB are Obtaining Fair Deals for their Shareholders Globe Newswire 6:27 PM

QGEN Stock Alert: Halper Sadeh LLC is Investigating Whether QIAGEN N.V. is Obtaining a Fair Price for its Shareholders Business Wire 9:03 AM

-- October 21, 2026 --

QIAGEN reports preliminary Q3 2026 results Business Wire 5:44 PM

QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer Business Wire 5:43 PM

-- October 13, 2026 --

QIAGEN Convenes Global Tuberculosis Experts as New Pressures Challenge Progress Against Tuberculosis Business Wire 4:05 PM

-- October 6, 2026 --

QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery Business Wire 4:05 PM

-- September 28, 2026 --

QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel Business Wire 1:30 AM

-- September 24, 2026 --

QIAGEN Launches QIAmini to Automate Small-Batch Sample Preparation Business Wire 4:05 PM

-- September 18, 2026 --

QIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing Board Business Wire 4:05 PM

-- August 28, 2026 --

10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences PRNewswire 2:39 PM

-- August 27, 2026 --

QIAGEN Launches QIAsymphony Connect for Automated Clinical Nucleic Acid Extraction Business Wire 4:05 PM

-- August 24, 2026 --

QIAGEN Appoints Jonathan M. Pratt as Chief Executive Officer Business Wire 9:47 AM

-- August 10, 2026 --

QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel Business Wire 4:05 PM

-- August 5, 2026 --

QIAGEN Exceeds Q2 2026 Outlook as Pillars Deliver Solid Sales Growth; Reaffirms Full-Year Outlook Business Wire 4:05 PM

-- July 15, 2026 --

QIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak Business Wire 4:05 PM

QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast Business Wire 8:48 AM

-- July 14, 2026 --

QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing Menu in Europe Business Wire 4:05 PM

-- June 15, 2026 --

QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma Business Wire 1:30 AM

Market Data Delayed 15 Minutes